Literature DB >> 12403073

Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.

René Holm1, Christopher J H Porter, Anette Müllertz, Henning G Kristensen, William N Charman.   

Abstract

PURPOSE: To compare the influence of triglyceride vehicle intramolecular structure on the intestinal lymphatic transport and systemic absorption of halofantrine in conscious rats.
METHODS: Conscious, lymph cannulated and nonlymph cannulated rats were dosed orally with three structurally different triglycerides; sunflower oil, and two structured triglycerides containing different proportion and position of medium-(M) and long-chain (L) fatty acids on the glycerol backbone. The two structured triglycerides were abbreviated MLM and LML to reflect the structural position on the glycerol. The concentration of halofantrine in blood and lymph samples was analyzed by HPLC.
RESULTS: Both the lymphatic transport and the total absorption of halofantrine were enhanced by the use the MLM triglyceride. The estimated total absorption of halofantrine in the lymph cannulated animals was higher than in the nonlymph cannulated animals, and this was most pronounced for the animals dosed with the structured triglycerides.
CONCLUSIONS: Using MLM as vehicle increases the portal absorption of halofantrine and results in similar lymphatic transport levels when compared to sunflower oil. Total absorption when assessed as absorption in the blood plus lymphatic transport for halofantrine after administration in the MLM triglyceride was higher than after administration in sunflower oil.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403073     DOI: 10.1023/a:1020311127328

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.

Authors:  C J Porter; S A Charman; A J Humberstone; W N Charman
Journal:  J Pharm Sci       Date:  1996-04       Impact factor: 3.534

2.  Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

Authors:  C J Porter; S A Charman; W N Charman
Journal:  J Pharm Sci       Date:  1996-04       Impact factor: 3.534

Review 3.  Drug delivery to the lymphatic system.

Authors:  C J Porter
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1997       Impact factor: 4.889

Review 4.  Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs.

Authors:  K M Wasan; S M Cassidy
Journal:  J Pharm Sci       Date:  1998-04       Impact factor: 3.534

5.  Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.

Authors:  R Holm; A Müllertz; G P Pedersen; H G Kristensen
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

6.  A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions.

Authors:  A J Humberstone; G J Currie; C J Porter; M J Scanlon; W N Charman
Journal:  J Pharm Biomed Anal       Date:  1995-03       Impact factor: 3.935

7.  The effect of triacyl-sn-glycerol structure on the metabolism of chylomicrons and triacylglycerol-rich emulsions in the rat.

Authors:  T G Redgrave; D R Kodali; D M Small
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

Review 8.  An examination of the factors affecting intestinal lymphatic transport of dietary lipids.

Authors:  B K Nordskog; C T Phan; D F Nutting; P Tso
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

Review 9.  Intestinal lymphatic drug transport: an update.

Authors:  C J Porter; W N Charman
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

10.  Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.

Authors:  A J Humberstone; C J Porter; G A Edwards; W N Charman
Journal:  J Pharm Sci       Date:  1998-08       Impact factor: 3.534

View more
  8 in total

Review 1.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

2.  The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).

Authors:  Maria Høtoft Michaelsen; Kishor M Wasan; Olena Sivak; Anette Müllertz; Thomas Rades
Journal:  AAPS J       Date:  2016-01       Impact factor: 4.009

3.  Bioavailability of seocalcitol IV: evaluation of lymphatic transport in conscious rats.

Authors:  Mette Grove; Jeanet L Nielsen; Gitte P Pedersen; Anette Müllertz
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

Review 4.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

5.  Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats.

Authors:  Verica Risovic; Michael Boyd; Eugene Choo; Kishor M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

6.  Comparisons of in vitro Fick's first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS.

Authors:  Jingyi Ye; Huiyi Wu; Chuanli Huang; Wanting Lin; Caifeng Zhang; Bei Huang; Banyi Lu; Hongyu Xu; Xiaoling Li; Xiaoying Long
Journal:  Int J Nanomedicine       Date:  2019-07-23

7.  In vivo Evaluation of Self Emulsifying Drug Delivery System for Oral Delivery of Nevirapine.

Authors:  A S Chudasama; V V Patel; M Nivsarkar; Kamala K Vasu; C J Shishoo
Journal:  Indian J Pharm Sci       Date:  2014-05       Impact factor: 0.975

Review 8.  Lipase-Catalyzed Interesterification for the Synthesis of Medium-Long-Medium (MLM) Structured Lipids - A Review.

Authors:  Qabul Dinanta Utama; Azis Boing Sitanggang; Dede Robiatul Adawiyah; Purwiyatno Hariyadi
Journal:  Food Technol Biotechnol       Date:  2019-09       Impact factor: 3.918

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.